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1. INTRODUCTION 
Natural products, including plants, animals and minerals have been the basis 
of treatment of human disease. History of medicine dates back practically to the 
existence of human civilization. The current accepted modern medicine or allopathic 
has gradually developed over the basis of its developed over the years by scientific 
and observational efforts of scientists.1 
Today estimate that about 80 % of people in developing countries still relays 
on traditional medicine based largely on species of plants and animals for their 
primary health care. Herbal medicines are currently in demand and their popularity is 
increasing day by day. About 500 plants with medicinal use are mentioned in ancient 
literature and around 800 plants have been used in indigenous systems of medicine. 
Natural products, especially those from plants, have been a valuable source 
of new cancer drugs for many decades. Medicinal plants are the most exclusive 
source of life saving drugs for the majority of the world’s population. The use of 
plant products in the treatment of cancer has been of recent interest .In the market; 
these products are offered as "natural products". Natural products appeared to be a 
promising source for new types of compounds to test for antitumor activity. The 
goals of using plants as sources of therapeutic agents are 
• To isolate bioactive compounds for direct use as drugs, e.g., digoxin, digitoxin, 
morphine, reserpine, taxol, vinblastine, vincristine. 
• To produce bioactive compounds of novel or known structures as lead 
compounds for semi synthesis to produce patentable entities of higher activity 
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and/or lower toxicity, e.g., metformin, nabilone, oxycodon and other narcotic 
analgesics], taxotere, teniposide, verapamil, and amiodarone, which are based, 
respectively, on galegine, tetrahydrocannabinol, morphine, taxol, 
podophyllotoxin, and khellin. 
• To use agents as pharmacologic tools, e.g., lysergic acid diethylamide, 
mescaline, yohimbine.2 
1.1. HERBAL MEDICINES 
Medicinal plants are the oldest known health care source. Their importance 
is still growing although it varies depending on the ethnological, medical and 
historical background of each country. Medicinal plants are also importance for 
pharmacological research and drug development, not only when plant constituents 
are used directly as basic materials for the synthesis of drugs or as models for 
pharmacologically active compounds. The World Health Organization (WHO) 
estimates that billion people, 80 percent of the world population, presently use 
herbal medicine for one or the other aspect of primary health care. Herbal medicine 
is a major component in all people’s indigenous traditional medicine and a 
common element in Ayurvedic, Homeopathic, Naturopathic, Traditional oriental 
and Native American Indian Medicine. 
Plants have provided the lead molecules for a large number of diseases. 
During the past 40 years numerous novel compounds have been isolated from plant 
sources and many of this substance have been demonstrated to possess interesting 
biological activities. 
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Approaches to natural product research and drug discovery 
Different approaches to drug discovery from plants can be enumerated as: 
random selection followed by chemical screening, random selection followed by one 
or more biological assays, follow-up of biological activity reports, follow-up of 
ethno-medical (traditional medicine) use of plants, use of appropriate plant parts as 
such in powdered form or preparation of enriched/standardized extracts (herbal 
product development), use of a plant product, biologically potent but beset with 
other issues, as a lead for further chemistry, and single new compounds as drugs. 
The objective of the later approach is the targeted isolation of new bioactive plant 
products, i.e. lead substances with novel structures and novel mechanisms of action. 
This approach has provided a few classical examples, but the problem most often 
encountered here is not enough availability. The problem of availability can be 
overcome by semi synthesis/ synthesis or using tissue-culture techniques (by 
genetically modifying the biosynthetic pathway of the compound of interest). 
Older approach 
• Focused on chemistry of compounds from natural sources, but not on activity. 
• Straightforward isolation and identification of compounds from natural sources 
followed by testing of biological activity in animal model. 
• Chemotaxonomic investigation. 
• Selection of organisms primarily based on ethno pharmacological information, 
folkloric reputations, or traditional uses. 
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Modern approach 
• Bioassay-directed (mainly in vitro) isolation and identification of active lead 
compounds from natural sources. 
• Production of natural products libraries. 
 
Figure 1: Steps involved in drug discovery from plants 
• Production of active compounds by cell or tissue culture, genetic manipulation, 
natural combinatorial chemistry and so on. 
• More focused on bioactivity. 
• Introduction of the concepts of dereplication, chemical fingerprinting, and 
metabolomics. 
• Selection of organisms based on ethno pharmacological information, folkloric 
reputations, or traditional uses, and also those randomly selected.3 
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Challenges in drug discovery from medicinal plants  
In spite of the success of drug discovery programs from plants in the past 2–
3 decades, future endeavors face many challenges. Natural products scientists and 
pharmaceutical industries will need to continuously improve the quality and quantity 
of compounds that enter the drug development phase to keep pace with other drug 
discovery efforts. The process of drug discovery has been estimated to take an 
average period of 10 years and cost more than 800 million dollars.4 It is estimated 
that only one in 5000 lead compounds will successfully advance through clinical 
trials and be approved for use. In the drug discovery process, lead identification is 
the first step. Lead optimization (involving medicinal and combinatorial chemistry), 
lead development (including pharmacology, toxicology, pharmacokinetics, ADME 
and drug delivery), and clinical trials all take considerable time. 
As drug discovery from plants has traditionally been time-consuming, faster 
and better methodologies for plant collection, bioassay screening, compound 
isolation and compound development must be employed. Innovative strategies to 
improve the process of plant collection are needed, especially with the legal and 
political issues surrounding benefit-sharing agreements.5 
The design, determination and implementation of appropriate, clinically 
relevant, high throughput bioassays are difficult processes for all drug discovery 
programs. The common problem faced during screening of extracts is solubility and 
the screening of extract libraries is many times problematic, but new techniques 
including pre-fractionation of extracts can alleviate some of these issues. Challenges 
in bioassay screening still remain an important issue in the future of drug discovery 
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from medicinal plants. The speed of active compound isolation can be increased 
using hyphenated techniques like LC-NMR and LC-MS. Development of drugs 
from lead compounds isolated from plants, faces unique challenges. Natural 
products, in general, are typically isolated in small quantities that are insufficient for 
lead optimization, lead development and clinical trials. Thus, there is a need to 
develop collaborations with synthetic and medicinal chemists to explore the 
possibilities of its semi-synthesis or total synthesis.6 One can also improve the 
natural products compound development by creating natural products libraries that 
combine the features of natural products with combinatorial chemistry. 
Opportunities in drug discovery from medicinal plants   
Bio prospecting demands a number of requirements which should be co-
coordinated, such as team of scientific experts (from all the relevant interdisciplinary 
fields) along with expertise in a wide range of human endeavors, including 
international laws and legal understanding, social sciences, politics and 
anthropology. In our context, Ayurveda and other traditional systems of medicine, 
rich genetic resources and associated ethno medical knowledge are key components 
for sustainable bio prospecting and value-addition processes. 
For drug-targeted bio prospecting an industrial partner is needed, which will 
be instrumental in converting the discovery into a commercial product. Important in 
any bio prospecting is the drafting and signing of an agreement or Memorandum of 
Understanding that should cover issues on access to the genetic resources 
(biodiversity), on intellectual property related to discovery, on the sharing of 
benefits as part of the process (short term), and in the event of discovery and 
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commercialization of a product (long term), as well as on the conservation of the 
biological resources for the future generations. When ethno botanical or ethno 
pharmacological approach is utilized, additional specific requirements that relate to 
prior informed consent, recognition of Indigenous Intellectual Property and 
Indigenous Intellectual Property Rights as well as short- and long-term benefit 
sharing need to be taken into account. 
In order to screen thousands of plant species at one go for as many bioassays 
as possible, we must have a collection of a large number of extracts. Globally, there 
is a need to build natural products extract libraries. The extract libraries offer various 
advantages, such as reduction in cost and time for repeat collection of plants and 
availability of properly encoded and preserved extracts in large numbers for 
biological screening in terms of high-throughput screenings and obtaining hits 
within a short period. Such libraries could serve as a powerful tool and source of 
extracts to be screened for biological activities using high-throughput assays.7 
1.2. DRUG DISCOVERY FROM NATURAL SOURCES 
For thousands of years, natural products have played an important role 
throughout the world in treating and preventing human diseases and disorders. The 
importance of natural products in modern medicine has been discussed in recent 
reviews and reports. The value of natural products in this regard can be assessed 
mainly by using three criteria: 
1. The rate of introduction of new chemical entities of wide structural diversity, 
including serving as lead molecule for semi-synthetic and total synthetic 
modification. 
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2. The number of diseases treated or prevented by these substances, and 
3. Their frequency of use in the treatment of disease. 
An analysis of the origin of the drugs developed between 1981 and 2003 
showed that natural products or natural product-derived drugs comprised 28% of 
all new chemical entities (NCEs) launched onto the market. In addition, about 24% 
of these  NCEs  were  synthetic  or  natural  mimic  compounds,  based  on  the  
study of pharmacophores related to natural products. This combined percentage 
suggests that the  natural  products  are  important  sources  for  new  drugs  and  
are  also  good    lead  compounds  suitable  for  further  modification  during  
drug  discovery  and development.8 
1.3. CANCER 
Cancer is a general term applied of series of malignant diseases that may 
affect different parts of body. These diseases are characterized by a rapid and 
uncontrolled formation of abnormal cells, which may mass together to form a 
growth or tumour, or proliferate throughout the body, initiating abnormal growth at 
other sites. If the process is not arrested, it may progress until it causes the death of 
the organism. The main forms of treatment for cancer in humans are surgery, 
radiation and drugs (cancer chemotherapeutic agents). Cancer chemotherapeutic 
agents can often provide temporary relief of symptoms, prolongation of life, and 
occasionally cures.9 
In recent years, a lot of effort has been applied to the synthesis of potential 
anticancer drugs. Many hundreds of chemical variants of known class of cancer 
chemotherapeutic agents have been synthesized but have a more side effects. A 
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successful anticancer drug should kill or incapacitate cancer cells without causing 
excessive damage to normal cells. This is difficult, or perhaps impossible, to attain 
and is why cancer patients frequently suffer unpleasant side effects when under-
going treatment. Synthesis of modifications of known drug continues as an 
important aspect of research. However, a waste amount of synthetic work has given 
relatively small improvements over the prototype drugs. There is a continued need 
for new prototype-new templates to use in the design of potential chemotherapeutic 
agents: natural products are providing such templates. Recent studies of tumor-
inhibiting compound of plant origin have yielded an impressive array of novel 
structures. 
Cancer cells manifest, to varying degrees, four characteristics that distinguish 
them from normal cells; 
 Uncontrolled proliferation 
 Dedifferentiation and loss of function 
 Invasiveness 
 Metastasis.9 
History10 
 Today, carcinoma is the medical terms for a malignant tumor derived from 
epithelial cells. It is Celsus who translated carcinos into the Latin cancer, also 
meaning crab.   Galen used “oncos” to describe all tumours, the root for the modern 
word oncology. Hippocrates descrbied several kinds of cancers.  He called benign 
tumours oncos, Greek for swelling, and malignant tumours carcinos, Greek for crab 
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or crayfish.  This name probably comes from the appearance of the cut surface of a 
solid malignant tumour, with a roundish hard centre surrounded by pointy 
projections, vaguely resembling the shape of a crab.  He later added the suffixoma, 
Greek for swelling, giving the name carcinoma.  Since it was against Greek tradition 
to open to body, Hippocrates only described and made drawings of outwardly visible 
tumors on the skin, nose, and breasts.  Treatment was based on the humor theory of 
four bodily fluids (black and yellow bild, blood, and phlegm).  According to the 
patient’s humor, treatment consisted of diet, blood-letting, and/or laxatives.  
Through the centuries it was discovered that cancer could occur anywhere in the 
body, but humor-theory based treatment remained popular until the 19th century with 
the discovery of cells. 
CAUSES OF CANCER11,12 
Modern medicine attributes most cases of cancer to changes in DNA that 
reduce or eliminate the normal controls over cellular growth, maturation, and 
Programmed cell death. These changes are more likely to occur in people with 
certain genetic backgrounds (as illustrated by the finding of genes associated with 
some cases of cancer and familial prevalence of certain cancers) and in persons 
infected by chronic viruses (e.g., viral hepatitis may lead to liver cancer; HIV may 
lead to lymphoma). The ultimate cause, regardless of genetic propensity or viruses 
that may influence the risk of the cancer, is often exposure to carcinogenic 
chemicals (including those found in nature) and/or to radiation (including natural 
cosmic and earthly radiation), coupled with a failure of the immune system to 
eliminate the cancer cells at an early stage in their multiplication. 
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 The immunological weakness might rise years after the exposure to 
chemicals or radiation. Other factors such as tobacco smoking, alcohol consumption, 
excess use of caffeine and other drugs, sunshine, infections from such oncogenic 
virus like cervical papilloma viruses, adenoviruses Kaposi’s sarcoma (HSV) or 
exposure to asbestos. These obviously are implicated as causal agents of mammalian 
cancers. However a large population of people is often exposed to these agents. 
Consequently cancer cells continue to divide even in situations in which normal 
cells will usually wait for a special chemical transduction signal. The tumor cells 
would ignore such stop signals that are sent out by adjacent tissues.  
 A Cancer cell also has the character of immortality even in vitro whereas 
normal cells stop dividing after 50-70 generations and undergoes a programmed cell 
death (Apoptosis). Cancer cells continue to grow invading nearby tissues and 
metastasizing to distant parts of the body. Metastasis is the most lethal aspect of 
carcinogenesis. 
TYPES OF CANCERS 9 
 1) Cancers of Blood and Lymphatic Systems: 
  a) Hodgkin's disease,   b) Leukemias,  
  c) Lymphomas  d) Multiple myeloma, 
  e) Waldenstrom's disease 
 2) Skin Cancer: 
  a)  Malignant Melanoma 
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 3) Cancers of Digestive Systems: 
  a) Esophageal cancer,   b) Stomach cancer,  
  c) Cancer of pancreas,   d) Liver cancer,  
  e) Colon and Rectal cancer  f) Anal cancer 
 4) Cancers of Urinary system: 
  a) Kidney cancer    b) Bladder cancer 
  c) Testis cancer   d) Prostate cancer 
 5) Cancers in women: 
  a)Breast cancer   b) Ovarian cancer 
  c) Gynecological cancer  d) Choriocarcinoma 
 6) Miscellaneous cancers: 
  a) Brain cancer   b) Bone cancer 
  c) Carcinoid cancer   d) Nasopharyngeal cancer, 
  e) Retroperitoneal sarcomas   f) Soft tissue cancer 
  g) Thyroid cancer  
Signs and symptoms13 
 Roughly, cancer symptoms can be divided into three groups. 
Local symptoms 
 Unusual lumps or swelling (tumor), hemorrhage (bleeding), pain and / or 
ulceration. Compression of surrounding tissues may cause symptoms such as 
jaundice. 
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Symptoms of metastasis (spreading) 
Enlarged lymph nodes, cough and hemoptysis, hempatomegaly (enlarged 
liver), bone pain, fracture of affected bones and neurological symptoms.  Although 
advanced cancer may cause pain, it is often not the first symptom.   
Systemic symptoms 
Weight loss, poor appetite and cachexia (wasting), excessive sweating (night 
sweats), anaemia and specific para-neoplastic phenomena, i.e., specific conditions 
that are due to an active cancer, such as thrombosis or hormonal changes. 
Figure 2. The Cell Cycle14 
 
Cellular multiplication involves passage of the cell through a cell cycle.  The 
various phases of the cell cycle are characterized as:  (i) the interval follow cell 
division to the point where DNA synthesis starts, known as the pre-synthetic phase 
(G1).  The variability in the length of the cell cycle between rapidly and slowly 
replicating cells is accounted by the differences in the length of (G1) phase; (ii) after 
mitosis some of the daughter cells pass into a resting phase or non-proliferative 
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phase (G0), and do not re-enter the cell cycle phase G1 immediately.  The may enter 
the G1 phase later.  The G0 phase is the sub phase of G1; (iii) the DNA synthesis(s) 
occurs; (iv) the pre mitotic or post synthetic (G2) phase follows.  In the phase RNA 
and protein synthesis take place, and it is shorter than the S phase; and (v) lastly 
mitotic (M0 phase follows, in which the synthetic activity of the cell is low the 
chromosomes separate in two daughter cells through the sub phase-prophase, 
metaphase, anaphase and telophase.  These daughter cells have the option of either 
entering the G1 phase or the G0 sub phase of G1 phase. 
 Cancers are caused by a series of mutations.  Each mutation alters the 
behaviour of the cell somewhat.   Carcinogenesis, when means the initiation or 
generation of cancer, is the process of derangement of the rate of cell division due to 
damage to DNA.  Proto-oncogenes are genes which promote cell growth and 
mitosis, a process of cell division, and tumour suppressor genes discourage cell 
growth, or temporarily halt cell division in order to carry out DNA repair.  
Typically, a series of several mutations to these genes are required before a normal 
cell transforms into a cancer cell. 
 Proto-oncogenes promote cell growth through a variety of ways.  Many can 
produce hormones, a “chemical messenger” between cells which encourage mitosis, 
the effect of which depends on the signal transduction of the receiving tissue or 
cells.  Some are responsible for the single transduction system and signal receptors 
in cells and tissues themselves, thus controlling the sensitivity to such hormones.  
They often produce mitogens, or they are involved in transcription of DNA in 
protein synthesis, which creates the proteins and enzymes responsible for producing 
the biochemical cells use and interact with Mutation sin proto-oncogenes can modify 
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their expression and function, increasing the amount or activity of the product 
protein.  When this happens, they become oncogenes, and thus cells have a higher 
chance to divide excessively and uncontrollably.  The chance of cancer cannot be 
reduced by removing proto oncogenes from the genome as they are critical for 
growth, repair and homeostasis of the body. 
Chemicals, viruses, irradiation etc 
Acquired mutation 
Altered gene expression 
 
Proto-oncogenes – 
oncogenes Sis, ras, myc, 
gene for cyclinD 
Expression of tumor 
suppressor genes p53 
 
Uncontrolled cell 
proliferation, 
Dedifferentiation 
 
Decreased apoptosis, 
Alterationin telomerase. 
 
Development of primary tumor 
Production of metalloprotekinase’s 
 
Invasion of nearby cells by tumor cells 
Angiogenesis 
Development of secondary tumors (pathogenesis of cancer) 
Chart No.1 
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Chemotherapy15,16 
Chemotherapy plays a significant role in the treatment of early stage disease, 
in the pro-operative period and as adjuvant therapy for the treatment of micro 
metastasis.  As knowledge has been accumulating in the area of pharmacology, 
tumor biology, cytokineties and resistance, therapeutic strategies have been 
developed that maximize the tumor-cell kill, decrease resistance and enhance the 
potential for cure by chemotherapy.  The antineoplastic armamentarium currently 
contains over 30 drugs, with many additional agents under investigation.  Human 
pituitary growth hormone, prostaglandins, cyclin-AMP, RNA-dependent DNA 
polymerase, etc also show promising results. 
 Since the differences between normal and neoplastic human cells are merely 
quantitative rather than qualitative, most antineoplastic drugs are associated with 
certain side effects.  The toxicity usually involves attack of drugs on rapidly 
proliferating normal body tissues such as bone marrow, hair follicles and intestinal 
epithelium.  In addition, individual drug may produce its own distinctive toxic 
effects on heart, lungs, kidneys and other organs.  Hence with some exceptions it can 
be said that the antineoplastic agents are generally palliative and not curative. 
 Many anti-cancer drugs (a) have a very narrow therapeutic index (b) is 
highly unable (c) are effective at very low concentration and (d) having unusual 
metabolic pathways. 
Drug designing for cancer17 
 In designing specific regimens for clinical use, a number of factors must be 
taken into account.  Drugs are generally more effective in combination and may be 
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synergistic through biochemical interactions.  These interactions are useful 
designing new regimens.  It is more effective to use drugs that do not share common 
mechanisms of resistance and that do not overlap in their major toxicities.  Drugs 
should be used as close as possible to their maximum individuals does.  And, finally, 
drugs should be used as close as possible to discourage tumour growth and 
maximize does intensity (the does gives per unit time, a key parameter in the success 
of chemotherapy).  Based on experimental tumour models, it is necessary to 
eradicate all tumour cells.  The fraction of cells killed with each treatment cycle is 
constant, with regrowth between cycles.  Thus, it is desirable to achieve maximal 
cell kill with each cycle, using the highest drug does possible, and to repeat does ad 
frequently as tolerated.  Since the tumour cell population in patients with visible 
disease exceeds 1gm, or 109 cells, and since each cycle of therapy kills less than 
99% of the cells, it is necessary to repeat treatment in multiple cycles to kill all the 
tumour cells.  
THE MECHANISM ON CANCER THERAPY12 
1. Inhibiting cancer cell proliferation directly by stimulating macrophage 
phagocytosis, enhancing natural killer cell activity. 
2. Promoting apoptosis of cancer cells by increasing production of interferon, 
interleukin-2 immunoglobulin and complement in blood serum. 
3. Enforcing the necrosis of tumor and inhibiting its translocation and spread by 
blocking the blood source of tumor tissue. 
4. Enhancing the number of leukocytes and   platelets by stimulating the 
hemopoietic function. 
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5. Promoting the reverse transformation from tumor cells into normal cells. 
6. Promoting metabolism and preventing carcinogenesis of normal cells. 
7. Stimulating appetite, improving quality of sleep, relieving pain, thus benefiting 
patient’s health. 
Plants in the Treatment of Cancer 18 
In the face of failure to fine synthetic drugs against cancer, thousands species 
of plants have been screened since a long time, for antineoplastic activity, in the 
hope of discovering effective natural products.  Compounds have been evaluated.  
Such work is still going on in several laboratories throughout the world.   The 
Natural Product Drug Development Program of the U.S. National Cancer Institute 
has identified about 3000 species of plants and animals as useful in dealing with one 
or the other aspect of cancer management.  Based on in vitro data, a large number of 
species have been identified to be of promise and taken to clinical trials.  However, 
products of hardly a handful of plant species, such as the Vinca alkaloids, Taxol, 
Camptothecin, Podophyllotoxin, etc., have passed through the rigorous tests to be 
officially used against certain types of cancer and are now available in the market.  
Yet there are severe problems associated with the use of even these largely 
‘successful’ drugs, which are among the most expensive plant products.  This 
reflects the complexity of the scenario of cancer drugs in general and plant base 
Evaluation of anticancer studies19 
Anticancer drugs can be evaluated by in vitro and in vivo methods. 
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In vitro methods 
Cytotoxicity: There is much pressure, both human and economic, to perform 
at least part of cytotoxicity testing in vitro.  Currently it is difficult to monitor 
systematic and physiological effects in vitro, so most assay determine effects at 
cellular level, or cytotoxicity broadly involve the metabolic alternation of the cells, 
including the death of cells as a result of toxic effects of the compounds. 
 The choice of assay will depend on agent on study, the nature of response, 
and the particular target cell.   In anticancer research, the in vitro screening involves 
estimation of cytotoxicity of the drug by different methods.  The commonly used 
methods of studying cytotoxicity are. 
 Determination of cell viability by Tryphan blue dye exclusion method 
In this method, viability dyes such as tryphan blue is used to determine 
membrane integrity.  Staining for viability assessment is more suited to suspension 
culture than to monolayer, because dead cells detach from the monolayer and are 
therefore lost from the assay.  The method has been applied with equal success to 
solid tumor, effusions and haematological malignancies. 
 Determination of cell viability by uptake of neutral red dye by the lysosome 
in neutral red assay. 
The uptake of neutral red by lysosome and Golgi bodies has been used to 
quantitative cell number.  The satin appears to be specific for viable cells, but the 
main limitation of the method is the difference in uptake between cell types.  Thus 
some cell types.  Thus some cell types, such as activated macrophages and fibroblast 
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take up amount very rapidly where as others, such as lymphocytes, show negligible 
staining. 
 Determination of cell metabolic function by protein estimation 
Several methods are available for measuring the protein contents of cell 
monolayers.  These include the use of Folin-ciocatechu reagent according to the 
method of Lowry and amino black. 
 Determination of quantitative value for the loss of cell viability by 
measurement of lactate dehydrogenase activity by LDH assay. 
The measurement of lactate dehydrogenase in culture supernatant gives a 
quantitative value for the loss of cell viability. 
Pyruvate + NADH + H + ⇔ NAD+ + lactate 
The activity of LDH can be measured as the reduction of Pyruvate to lactate.  
The reduction is coupled to the oxidation of NADH to NAD, which is followed 
spectrophotometrically at 340nm. 
 Sulphoromamine B (SRB) assay. 
SRB is a pink amino xanthine dye with two sulfonic groups.   Under mild 
acidic condition, SRB binds to protein basic amino acid residue in (trichloroacetic 
acid) fixed cells to provide a sensitive index of cellular protein content that is linear 
over a cell density range of visible at least two order of magnitude.  Colour 
development of SRB assay is rapid, stable, and visible.  The developed colour can be 
measured over a broad range of visible wavelength in 90-microliter plate readers. 
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 Cytotoxicity by Micro culture Tetrazolium (MTT) assay 
The ability of the cell to survive a toxic insult has been the basis of most 
Cytotoxic assays.  This assay is based on the assumption that dead cell or their 
products do not reduce Tetrazolium salt (3-(4, 5 dimethyl thiazole – 2yl) –2, 5 – 
diphenyl Tetrazolium bromide) into a blue colored product (formazan) by 
mitochondrial enzyme succinate dehydrogenase.  The numbers of cell are found to 
be proportional to the extent of formazan production by cells used. 
In vivo methods 
 Fibro sarcoma solid tumour model. 
 EAC model (Ehrlich ascites carcinoma).    
  Chemically induced cancer model.                                                                                                                                               
 Virus induced cancer model. 
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2. PLANT PROFILE 
. Plant Leucas aspera (Willd.) Link 
Plant Profile 
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Taxonomical Classification 
Kingdom   :  Plantae 
Class    :  Dicotyledonae 
Series    :  Bicarpellatae 
Order    :  Tubiflorae 
Family    :  Lamiaceae 
Genus    :  Leucas 
Species   :  Aspera 
Vernacular Names  
Sanskrit   :  Dronapushpi, Chitrapathrika     
Tamil                          : Thumbai 
English   :  Thumbai 
Hindi     : Goma madhupati 
Botanical description: 
Leucas aspera is an annual, branched, herb erecting to a height of 15-60 cm 
with stout and hispid acutely quadrangular stem and branches.  
Leaves: Leaves are sub-sessile or shortly petiolate, linear or linearly 
lanceolate, obtuse, pubescent up to 8.0 cm long and 1.25 cm broad, with entire or 
crenate margin; petiole 2.5-6 mm long.  
Flowers:  white, sessile small, in dense terminal or axillary whorls; bracts 6 
mm long, linear, acute, bristle-tipped, ciliate with long slender hairs. 
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Calyx: calyx variable, tubular, 8-13 mm long; tube curved, contracted above 
the nuttiest, the lower half usually glabrous and membranous, the upper half ribbed 
and hispid; mouth small, very oblique, not villous, the upper part produced forward; 
teeth small, triangular, bristle-tipped, ciliate, the upper tooth being the largest.  
Corolla: Corolla 1 cm long; tube 5 mm long and pubescent above, annulate 
in the middle; upper lip 3 mm long, densely white-woolly; lower lip about twice as 
long, the middle lobe obviate, rounded, the lateral lobes small, subacute. 
Fruits: Fruit nutlets, 2.5 mm long, oblong, brown, smooth, inner face 
angular and outer face rounded.
20
 
Chemical Constituents: 
Fruit : Alkaloids 3.5% – 5%, aromatic oil, resins, glycosides, Carbohydrates,  
  saponins and triterpenoids. 
Stem : Saponins, phytosterols, tannins and carbohydrates. 
Root : Reducing sugars, phenolic compounds, saponins, xanthoproteins,  
  alkaloids, triterpenoids and flavonoids. 
Leaves  :  Flavonoids, alkaloids, steroids, resins, saponins and proteins.
21, 22
 
Economic uses/values/harmful aspects  
 The plant is used traditionally as an antipyretic and insecticide.  
 Flowers are valued as stimulant, expectorant, diaphoretic, insecticide. 
 Leaves are considered useful in chronic rheumatism, psoriasis and other chronic 
skin eruptions.  
 Bruised leaves are applied locally in snake bites.
23
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3. LITERATURE REVIEW 
3.1. Larvicidal activity of Leucas aspera 
 Suganya G et al., evaluated the silver nanoparticles synthesized from Leucas 
aspera leaf extract against dengue vector Aedes aegypti. The results suggested that 
the synthesized AgNP from leaf extracts have a higher larvicidal potential as 
compared to crude solvent extracts.24 
 Elumalai D et al., evaluated the larvicidal activity of isolated compound 
catechin from the whole-plant methanol extract of Leucas aspera on the fourth-in 
star larvae of Aedes aegypti, Anopheles stephensi, and Culex quinquefasciatus. The 
results showed pronounced larvicidal activity at very low concentrations.25 
 Kovendan K et al., studied larvicidal effect and pupicidal activity of Leucas 
aspera against malarial vector, Anopheles stephensi Liston. (Diptera: Culicidae). 
This study results showed, the ethanol extract of Leucas aspera and B. sphaericus 
exhibited an excellent controlling of malarial vector, A. stephensi.26 
3.2. Antimicrobial and antibacterial activity of Leucas aspera 
 A study by Rahman MA et al., showed that the ethanol extract of Leucas 
aspera has a potent radical scavenging activity and antibacterial activity against 
various gram positive and gram negative species.27  
 Chew AL et al., evaluated the antimicrobial and cytotoxic effect of different 
parts of  Leucas aspera (root, flower, leaf and stem) and found that methanol extract 
of root possessed better antioxidant activity compared to standard. Crude extracts of 
root, flower, leaf and stem showed notable antibacterial activity against tested 
microorganisms.28 
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 Mangathayaru K et al., demonstrated the antimicrobial activity of methanol 
extract from Leucas aspera flowers. The fractions of alkaloidal residue and flower 
juice tested for antimicrobial activity, showed good antibacterial activity with 
maximum activity for the alkaloidal residue.29 
3.3. Antiulcer activity of Leucas aspera 
 Reddy MK et al., investigated, 90% alcoholic extract of Leucas aspera in 
two experimental models. The observed results showed that Leucas aspera 
possesses antiulcer effect and significantly reduced acid secretion.30 
3.4. Antipsoriatic activity of Leucas aspera 
 Antipsoriatic activity of Phyllanthus simplex Retz. (Phyllanthaceae), 
Crotolaria juncea Linn. (Leguminosae), Leucas aspera Linn. (Lamiaceae), and 
Vitex glabrata R.Br. (Verbenaceae) were compared by Singh SK et al.31 Study 
findings revealed that these plants showed skin keratinocyte antiproliferative 
activity. Amongst, petroleum ether extract of C. juncea and ethanol extract of 
Leucas aspera were found to have significant activity. 
3.5. Antihyperglycemic activity of Leucas aspera 
 The antihyperglycemic activity of Leucas aspera leaf and stem was 
compared with Lannea Coromandelica (Houtt.) bark in Mice by Mannan A, et al.,32 
from bangladesh. This study showed that antihyperglycemic effect of methanol leaf 
extract of Leucas aspera was slightly better than the stem extract.  
 Gupta and coworkers33 compared ethanol extracts of Leucas aspera and 
Lannea coromandelica for anti-diabetic activity. Their study results showed Leucas 
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aspera and Lannea coromandelica are capable of exhibiting antihyperglycemic 
activity in alloxan and streptozotocin-induced diabetic rats.  
 Tukaram et al., evaluated the ethanol extract of Leucas aspera leaves on 
alloxan-induced type-1 DM. The study found that the crude extract ameliorate the 
hyperglycemia in alloxan-induced rats.34 
3.6. Thrombolysis and cytotoxicity effect of Leucas aspera 
 Rahman MA et al., compared thrombolysis and cytotoxic effect of six 
Bangladesh plants. This study showed Clausena suffruticosa, Leea indica and 
Leucas aspera having effective thrombolytic properties than Senna sophera and 
Solanum torvum. None of these plant extracts showed any cytotoxic effect compared 
to positive control.35   
3.7. Anti-inflammatory and adjuvant arthritis activity of Leucas aspera 
 Kripa KG et al., investigated the anti-inflammatory activity of ethanol extract 
of Leucas aspera in adjuvant arthritis. In this study Freund's adjuvant served to 
induce arthritis. Ethanol extract of Leucas aspera exhibited significant anti-
inflammatory and antioxidant activity. No mortality was observed in doses up to 
2000 mg/kg body weight. This study highlighted the antioxidant and anti-
inflammatory potential of Leucas aspera due to the presence of catechins 
(epicatechin, beta epicatechin), flavonoids (procyanidin), phytosterols (beta-
sitosterol) apart from glycosides, phenolic compounds and tannins.36 
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3.8. Hepatoprotective and antioxidant activity of Leucas aspera 
 Banu S et al., studied the hepatoprotective effect of whole plant extract 
of Leucas aspera in d-galactosamine (D-GalN)-induced hepatotoxicity in rats. 
Biochemical and histopathological studies were performed to assess 
hepatoprotective activity. Hexobarbitone - induced sleeping time model was used to 
study the protective effect of Leucas aspera on microsomal drug metabolizing 
enzymes. Pretreatment with Leucas aspera extract significantly protected the liver in 
D-GalN administered rats and significantly elevated antioxidant enzymes like 
superoxide dismutase, catalase, glutathione peroxidase and decreased lipid 
peroxidation levels in liver.37 
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4. AIM AND PLAN OF WORK 
As know that everything in this world change time by time, since thousands 
of year the era was of ayurveda or herbal origin drug.  But last few decades it was 
replaced by allopathic system of medicine, which was lastly accepted worldwide, 
but latter due to its lot of adverse effect, again men step down on ayurveda because 
of its better therapeutic result and safety profile and now the people are more 
believing in natural origin drug. 
 Numerous drugs have entered in the International Pharmacopoeia through 
the study of Ethno pharmacology and traditional medicines.  For ayurveda and other 
traditional medicines newer guidelines of standardization, manufacture and quality 
control are required.  Employing a unique holistic approach, ayurveda medicines are 
usually customized to an individual constitution, Traditional knowledge, driven drug 
development can follow a reverse pharmacology path and reduce time and cost of 
development.  Powerful search engine and most importantly, will greatly facilitate 
international, focused and safe natural product research to rediscover the drug 
discovery process. 
 Looking to the scope of herbal drug and increasing demand especially in 
case of diseases like liver disorders, hypertension, diabetes, cancer, diarrhoea, 
arthritis and skin diseases, etc., it was planned to study a plant like Leucas aspera 
(Willd.) Link which is having a variety of traditional uses. This plant is selected for 
present study based on its easy availability; degree of research work which is not 
done. The literature survey revealed that some amount of pharmacological work has 
been carried out on Leucas aspera (Willd.) Link.  So in order to explore the 
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activities and phytoconstituents present in the whole plant of Leucas aspera (Willd.) 
Link,. planned to go for the following studies. 
PLAN OF WORK  
 The work was planned as under mentioned 
PHYTOCHEMICAL STUDIES 
 Collection and authentication of plant material 
 Extraction of the plant material. 
 Preliminary phytochemical screening of the extract. 
 Thin layer chromatography of the extract. 
 Isolation of plant constituent by column chromatography. 
 Characterization of isolated compound by IR, NMR, Mass spectroscopy. 
PHARMACOLOGICAL STUDIES  
In vitro anticancer activity 
1. Cell treatment procedure  
2. MTT Assay 
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5. MATERIALS AND METHODS 
Table 1: Chemicals 
S. No. Chemicals Supplier/ manufacture 
1. Petroleum ether (60 - 80 ºC) Loba chemical pvt.ltd., Mumbai 
2. Ethanol (90 %) Merck-Schuchardt, Mumbai 
3. Silica gel-G (TLC grade) Loba chemical pvt.ltd., Mumbai 
 4. Silica gel G (60 - 120 mesh) E merck- Germany 
 5. Hexane Loba chemical pvt.ltd., Mumbai 
6. Ethyl acetate Loba chemical pvt.ltd., Mumbai 
 
Table 2: Instruments and Equipments 
S. 
No. Equipments/Instruments Model Manufacture 
1. Hot air oven Geninuine Shivani Scientific industries 
2. Electronic weighing Balance BT 2245 Surtorius 
3. Melting point apparatus MRVIS Lab India 
4. IR Spectrophotometer Bruker optik  GMBH Germany 
5. NMR- Spectrophotometer 
Bruker AVIII 
Avance FT  
NMR 
Germany 
6. Mass spectrophotometer JEOL GCmate Germany 
7. Soxhlet apparatus Borosil Chennai 
 
COLLECTION OF PLANT 
 The whole plant of Leucas aspera (Willd.) Link was collected from 
surrounding areas of komarapalayam and sankagiri, Namakkal District, Tamilnadu, 
India and the specimen was preserved in our Pharmacognosy Lab, JKKN College of 
Pharmacy, Komarapalayam for further reference. 
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AUTHENTICATION OF PLANT 
The plant was authenticated by Mr. G.V.S. Murthy, scientist F, Botanical 
survey of India, Coimbatore, Tamilnadu (No. BSI/SRC/5/23/2016-17/Tech). 
EXTRACTION PROCEDURE 
The whole plant of Leucas aspera (Willd.) Link were dried under shade, 
mixed together and then made in to a coarse powder with a mechanical grinder.  The 
powder was passed through sieve no. 40 and stored in an airtight container for 
further use.  The dried powder material (150 gm) was defatted with petroleum ether 
(60 - 80 oC) to remove waxy substances and chlorophyll, which usually interfere in 
the isolation of phytoconstituents.  The marc after defatted with petroleum ether was 
dried and extracted with ethanol (90 % v/v) in a soxhlet extractor for 72 hr.  The 
solvent was then distilled off and the resulting semisolid mass was dried in a 
vacuum evaporator and yield was calculated. 
PRELIMINARY PHYTOCHEMICAL ANALYSIS38-41   
 The extracts of Leucas aspera (Willd.) Link was subjected to qualitative tests 
for the identification of various plant constituents. 
1) TEST FOR ALKALOIDS 
(a) Dragendorff’s test: 1 ml of the extract was added with 1 ml of dragendorff’s 
reagent (potassium bismuth iodide solution). An orange red precipitate indicates 
the presence of alkaloids. 
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(b) Mayer’s Test: 1 ml of the extract was added with 1 ml of mayer’s reagent 
(potassium mercuric iodide solution). Whitish yellow coloured precipitate 
indicates the presence of alkaloids. 
(c) Hager’s Test: 1 ml of the extract was added with 3 ml of hager’s reagent 
(saturated aqueous solution of picric acid), yellow coloured precipitate indicates 
the presence of alkaloids. 
(d) Wagner’s Test: 1 ml of the extract was added with 2 ml of wagner’s reagent 
(Iodide in potassium Iodide), formation of reddish brown precipitate indicates 
the presence of alkaloids. 
(e) Tannic acid Test: 1 ml of the extract was added with 1 ml of 10% tannic acid 
solution, buff coloured indicates the presence of alkaloids. 
2) TEST FOR SAPONINS 
(a) Foam Test: The extract was diluted with 20 ml of distilled water and shaken in 
a graduated cylinder for 15 min lengthwise. A 1 cm layer of foam indicates the 
presence of Saponins. 
(b) Lead acetate Test: 1 ml of sample solution was treated with 1% lead acetate 
solution, formation of white precipitate indicate the presence of saponins. 
(c) Heamolytic Test: The extract or dry powder was added one drops of blood 
placed on glass slide. If heamolytic zone appears shows the presence of 
saponins. 
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3) TEST FOR GLYCOSIDES 
(a) Legal’s Test: Dissolved the extract in pyridine and added sodium nitroprusside 
solution to make it alkaline. The formation of pink red to red colour shows the 
presence of glycosides.  
(b) Baljet Test: 1 ml of the test extract was added with 1 ml of sodium picrate 
solution and the yellow to orange colour shows the presence of glycosides. 
(c) Keller- Killiani Test: The ethanol extract 0.5 ml of strong solution of lead 
acetate was added and filtered. The filtrate is shaken with 5 ml of chloroform. 
The chloroform layer is separated in a porcelain dish and removes the solvent 
by gentle evaporation. Dissolve the cool residue in 3 ml of glacial acetic acid 
containing 2 drops of ferric chloride solution. Carefully transferred this solution 
to the surface of 2 ml of concentrated sulphuric acid. A reddish brown layer 
forms at the junction of the two liquids and the upper layer slowly becomes 
bluish green, darkening with standing. 
(D) Borntrager’s Test: Added a few ml of dilute sulphuric acid to 1 ml of the 
extract solution. Boiled filtered and extracted the filtrate with chloroform the 
chloroform layer was treated with 1 ml of ammonia. The formation of red 
colour of the ammonical layer shows the presence of anthraquinone glycosides. 
4) TEST FOR CARBOHYDRATES AND SUGARS 
(a) Molisch’s Test: 2 ml of the extract was added with 1 ml of α- napthol solution 
was added and also added concentrated sulphuric acid through the side of the 
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test tube. Reddish violet colour at the junction of the two liquids indicates the 
presence of carbohydrates. 
(b) Fehling’s Test: 1 ml of the extract was added with equal quantities of Fehling 
solution A and B were added, upon heating formation of a brick red precipitate 
indicates the presence of reducing sugars. 
(c) Benedict’s test: 1 ml of extract was added with 5 ml of benedict’s reagent, 
was added and boiled for 2 min. and cool. Formation of red precipitate shows 
presence of sugars.  
(d) Tollen’s Test: 1 ml of extract was added with 2 ml of tollen’s reagent was 
added and boiled. A silver mirror is obtained inside the wall of the tube which 
indicates the presence of aldose sugar. 
(e) Seliwanoff’s Test: The extract was treated with hydrochloric acid and 
resorcinol and heated. Formation of red colour shows presence of glucose. 
(f) Bromine water Test: The little quantity of test extract, bromine water was 
added. Bromine water decolourization indicates the presence of aldose sugar. 
 5) TEST FOR TANNINS 
(a) Gelatin Test: 1 ml of extract was added with 1% gelatin solution containing 
10% sodium chloride. Formation of white precipitate indicates the presence of 
tannins. 
(b) Ferric chloride Test: 1 ml of extract was added with 1ml ferric chloride 
solution, formation of dark blue or greenish black product shows the presence 
of tannins. 
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(c) Vanillin hydrochloride Test: 1 ml of extract was added with vanillin 
hydrochloride. Formation of purplish red colour indicates the presence of 
tannins. 
(d) Lead acetate Test: Taken a little quantity of test solution was taken and mixed 
with basic lead acetate solution. Formation of white precipitate indicates the 
presence of tannins. 
(e) A little quantity of test extract was treated with potassium ferric cyanide and 
ammonia solution. A deep red colour indicates the presence of tannins. 
(f) Potassium dichromate Test: The sample solution was treated with 1ml of 10% 
Potassium dichromate solution gives yellowish brown precipitate indicates the 
presence of tannins. 
6) TEST FOR FLAVONOIDS 
(a) Shinoda’s Test: The extract solution, few fragments of magnesium ribbon was 
added and add concentrated HCL drop wise gives cherry red colour appears 
after few minutes, shows the presence of flavonoids. 
(b) Alkaline reagent Test: The extract was treated with sodium hydroxide; 
formation of yellow colour indicates the presence of flavonoids. 
(c) Little quantity of extract was treated with lead acetate, a yellow colour solution 
formed, disappears on addition of an acid indicates the presence of flavonoids. 
(d) The extract was treated with concentrated sulphuric acid, formation of yellow or    
orange colour indicates the presence of flavonoids. 
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7) TEST FOR STEROIDS 
(a) Libermann- Burchard’s Test: 2 ml of extract was added with chloroform 
solution, 1-2 ml of acetic anhydride and 2 drops of concentrated sulphuric acid 
was added along the sides of the test tube. Appearance of bluish-green colour 
shows the presence of steroids.  
(b) Salkowsky’s Test: Dissolve the extract in chloroform solution, 2 ml conc. 
sulphuric acid was added. If chloroform layer appear red colour indicate the 
presence of steroids. 
8) TEST FOR PROTEINS AND AMINO ACIDS 
(a) Biuret Test: 1 ml of the extract was treated with 4% NaOH and few drops of 
CuSO4 solution, Formation of purple violet colour indicate the presence of 
proteins. 
(b) Ninhydrin Test: 1 ml of the extract was treated with 3 drops of 5% Ninhydrin 
solution in boiling water bath for 10 min; formation of purplish or bluish colour 
appearance indicates the presence of proteins, peptides or amino acid. 
(c) Xanthoproteic Test: 1 ml of the extract was treated with 1 ml of concentrated 
nitric acid. A white precipitate formed, it was boiled and cooled. Then 20% of 
sodium hydroxide or ammonia is added. Orange colour indicates the presence 
of amino acids. 
(d) Millon’s Test: 1 ml of the extract was treated with millon’s reagent (mercuric 
nitrate in HNO3) white precipitate turns to brick red indicate the presence of 
proteins. 
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9) TEST FOR TRITERPENOIDS 
(a) Knoller’s Test: Dissolved 2 or 3 granules of tin metal in 2 ml thionyl chloride 
solution. Then added 1 ml of the extract into the test tube and warm, the 
formation of pink colour indicates the presence of Triterpenoids. 
10) TEST FOR FIXED OILS AND FATS 
(a) Spot Test: Pressed a small quantity of extract between two filter papers, the 
stain on the filter paper indicates the presence of fixed oils.  
(b) Saponification Test: Added a few drops of 0.5 N of alcoholic potassium 
hydroxide to small quantity of various extract along with a drop of 
phenolphthalein separately and heat on water bath for 1 to 2 hrs. The formation 
of soap or partial neutralization of alkali indicates the presence of fixed oils 
and fats. 
11) TEST FOR GUMS AND MUCILAGE 
 10 ml of extract was slowly added 25ml of absolute alcohol with constant 
stirring, filtered the precipitate and dried in air. The precipitate for its swelling 
property indicates the presence of carbohydrates. 
THIN LAYER CHROMATOGRAPHY42, 43 
 Thin layer chromatography as a procedure for analytical adsorption 
chromatography was first introduced by Stahl (1958) who was mainly responsible 
for bringing out standard equipment for preparing thin layers. It is not present an 
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important analytical tool for qualitative and quantitative analysis of a number of 
natural products, for separation and estimation of different components. 
 The principle of separation is adsorption.  One or more compounds are 
spotted on a thin layer of adsorbent coated on TLC plate.  The mobile phase flows 
through because of capillary action (against gravitational force).  The component 
moves according to their affinity towards the stationary phase.  The component with 
lesser affinity towards the stationary phase travels faster and vice versa thus leading 
to the separation of components.  The information provided by a finished 
chromatography includes the “migrating behaviour” of the separated substances.  It 
is given in the form of Rf value (relative to front). 
Rf = 
solventbytravelledDistance
solutebytravelledDistance
 
Rf value usually lies in the range of 0.1 – 1. 
PROCEDURE 
1. Preparation of plate 
 The silica gel G (60-120 mesh) (Fischer & Co) was utilized for the 
preparation of TLC plates.  Silica gel G was mixed with sufficient quantity of water 
and triturated will to make slurry.  The prepared slurry was spread on the 
meticulously cleaned and scratch free glass plates of definite dimension by using a 
TLC spreader.  The thickness of the absorbent was adjusted to 2 mm throughout the 
plate.  Then the prepared plates were allowed to set for 15-30 minutes.  The 
activated plates were stored in a vacuum desiccator for future use.  Also prior to use 
the plates were once again activated. 
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2. Development of Chromatogram 
 The saturation of atmosphere of TLC chamber by mobile phase before the 
start of the experiment is almost important to avoid the flawed results due to tailing 
effect.  The sample was spotted on the plate 2 cm away from the bottom.  The plate 
was then developed in the chamber by allowing the plate to run up to ¾ th distance 
of the plate.  The plate was then removed dried up to room temperature and sprayed 
with suitable spray reagent or kept in iodine chamber for identification of spots of 
TLC pattern of ethanol extract of Leucas aspera (Willd.) Link. 
COLUMN CHROMOTAGRAPHY44-46 
 The column chromatographic technique is widely used for separation, 
isolation, and purification of the natural products.  The principle underlying the 
separation of the compounds is adsorption at the solid liquid interface.  For the solid 
support and the interaction between adsorbent and component must be reversible.  
As the adsorbent is washed with fresh solvent the various components will therefore 
move down the column until, ultimately, they are arranged in order of their affinity 
for the adsorbent.  Those with least affinity move down the column at a faster rate 
than, and are eluted from the end of the column before, those with greatest affinity 
for the adsorbent.  By changing the polarity of the mobile phase, the separation can 
be achieved by column chromatography.  Characterization of the isolated 
compounds can be carried out by analytical techniques, like IR, NMR and Mass 
spectroscopy. 
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Chromatography 
Among the various methods of separating plant constituents, the 
chromatographic procedure originated by Tswett is one of the most commonly used 
techniques of general application. 
Chromatography is a separation process, which depends on the differential 
distribution of the components of a mixture between a mobile bulk phase and an 
essentially thin film stationary phase.  The stationary phase may be either in the 
form of packed column (Column Chromatography) through which a mobile phase is 
allowed to flow, or in the form of a thin layer adhering to a suitable form of packing 
material (Thin-layer chromatography) over which the mobile phase is allowed to 
ascend by capillary action.  The thin film stationary phase may be either a liquid or a 
solid, and the mobile phases are liquid or a gas.  Possible of these phases then give 
rise to the principal chromatographic techniques in general uses. The separation and 
isolation of individual pure compound from a plant extract, is achieved by resorting 
to one or more of the various chromatographic techniques which are now available.   
There include 
 Paper chromatography (PC) 
 Thin layer chromatography (TLC) 
 Column chromatography (CC) 
 Flash chromatography 
 Low pressure liquid chromatography  
 High pressure liquid chromatography (HPLC) 
 Gas liquid chromatography (GLC) 
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Among these, the most widely used methods are PC, TLC, GLC, and HPLC. 
For isolation of gram quantities of compounds, chromatography over a column of a 
suitable adsorbent is the most convenient method.  Column chromatography is the 
widely used methods to isolate the active constituent, in its pure form, from the 
crude extract or fractions.  The main principal involved in the column 
chromatography is adsorption at the solid liquid interface.  Each compound is a 
mixture will have a particular solubility in the solvent and a particular tendency to 
be absorbed by the solid adsorbent; no two compounds mostly behave exactly alike 
in these respects. 
Details of Column Chromatography 
 On the basis of phytochemical screening and TLC study, the ethanol extract 
of Leucas aspera (Willd.) Link and the solvent system were selected for column 
chromatography by isocratic elution method. 
Details of column chromatography 
Adsorbent - Silica gel for column chromatography (60-120# mesh) 
Solvent system  - Toluene: Ethyl acetate: Acetic acid (55: 45: 1) 
Length of column  - 60 cm 
Diameter of column  - 2 cm 
EELA used -  5 gm 
Rate of elution - 20 drops per minute  
Fraction collected - 40 fractions each of 25 ml 
Method of column packing - Wet packing 
Technique  -  Isocratic elution 
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Procedure for preparation of column: 
1. The silica gel 60-120 mesh was made into slurry with selected solvent system 
(Toluene: Ethyl acetate: Acetic acid (55: 45: 1), The silica gel previously 
activated by heating in hot air oven at 100 ºC for 1hr. 
2. The bottom of the column was plugged by cotton and then the silica gel slurry 
was poured into the column which was filled with solvent system up to 40 cm 
height, after that it was set aside for 10 minutes and allowed to settle. 
3. The Ethanol extract of Leucas aspera (Willd.) Link was mixed with small 
amount of silica gel and wetted with solvent system and mixed well and allowed 
to evaporate the solvent to set the dry residue. 
4. Then the dry residue was charged on column with the help of solvent system, 
after that cotton was placed over it, in order to avoid the disturbance of the top 
layer of the adsorbent as fresh mobile phase was added to the column. 
5. The column was eluted with the selected solvent system by Isocratic method and 
the fractions were collected in clean 100 ml beaker up to 25 ml with the speed of 
drops was 20 drops/minute. 
Each collected fraction was tested for the presence of various constituents by 
TLC for the number of types of constituent and similar fractions were pooled 
together.  
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SPECTRAL CHARACTERIZATION 
FT-IR Spectroscopy 
 Isolated compound was analysed by IR spectral studies by using KBr pellet 
technique. In this method, the drug and KBr were mixed at the ratio of 1:100. Then 
these mixtures were pressed in to a pellet. The FT-IR spectra were recorded for 
isolated compounds, by using KBr pellet method in the region of 4000-400 cm-1.  
NMR Spectroscopy 
 NMR is used to elucidate the structure of an unknown compound, there are 
three pieces of information which should be considered, the position of resonance of 
the peak (or chemical shift), the number of hydrogen atoms causing the signal 
(integration) and the number of peaks constituting the signal (multiplicity). NMR 
data to solve the structure but it is equally acceptable to use MS or IR data to solve 
the unknown. 
MASS Spectroscopy 
Mass spectrometry (MS) is an analytical technique that measures the mass-
to-charge ratio of charged particles. It is used for determining masses of particles, 
for determining the elemental composition of a sample or molecule, and for 
elucidating the chemical structures of molecules, such as peptides and other 
chemical compounds. The MS principle consists of ionizing chemical compounds to 
generate charged molecules or molecule fragments and measurement of their mass-
to-charge ratios.47, 48  
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Phase II: PHARMACOLOGICAL STUDIES 
IN VITRO ANTICANCER ACTIVITY 
The human breast cancer cell line (MCF-7) and cervical cancer cell lines 
(HeLa) were obtained from National Centre for Cell Science (NCCS), Pune. The 
(MCF-7) cells were grown in Dulbecco’s modified eagles medium (DMEM) and 
HeLa cells were grown in Eagles minimum essential medium (EMEM) containing 
10% fetal bovine serum (FBS). All cells were maintained at 37 oC, 5% CO2, 95% air 
and 100% relative humidity. Maintained cultures were passaged weekly and the 
culture medium was changed twice a week. 
CELL TREATMENT PROCEDURE 
 The monolayer cells were detached with trypsin – ethylene diamine tetra 
acetic acid (EDTA) to make single cell suspensions and viable cells were counted 
using a haemocytometer and diluted with medium with 5% FBS to give final density 
of 1x105 cells/ml. one hundred microlitres per well of cell suspension were seeded 
into 96-well plates at plating density of 10,000 cells/well and incubated to allow for 
cell attachment at 37 oC, 5% CO2, 95% air and 100% relative humidity.  
After 24 hr the cells were treated with serial concentrations of the extracts 
and fractions. They were initially dissolved in dimethylsulfoxide (DMSO) and 
further diluted in serum free medium to produce five concentrations. One hundred 
microlitres per well of each concentration was added to plates to obtain final 
concentrations of 10, 20, 50, 100, 200 µg/ml. The final volume in each well was 200 
µl and the plates were incubated at 37oC, 5% CO2, 95% air and 100% relative 
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humidity for 48 hr. The medium containing without samples were served as control. 
Triplicate was maintained for all concentrations. 
MTT ASSAY 
 MTT is a yellow water soluble tetrazolium salt. A mitochondrial enzyme in 
living cells, succinate-dehydrogenase, cleaves the tetrazolium ring, converting the 
MTT to an insoluble purple formazan. Therefore,the amount of formazan produced 
is directly proportional to the number of viable cells. 
 After 48 hr of incubation, 15 µl of MTT (5 mg/ml) in phosphate buffered 
saline (PBS) was added to each well and incubated at 37oC for 4 hr. The medium 
with MTT was then flicked off and the formed formazan crystals were solubilized in 
100 µl of DMSO and then measured the absorbance at 570 nm using micro plate 
reader. The % cell inhibition was determined using the following formula.  
% cell Inhibition = 100- Abs (sample)/Abs (control) X 100.  
Nonlinear regression graph was plotted between percent cell inhibition was 
determined using Microsoft Excel software.49, 50 
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6. RESULTS AND DISCUSSION 
The whole plant of Leucas aspera (Willd) Link belonging to family 
Lamiaceae has been investigated in a sytematic way covering phytochemical 
characterization and pharmacological studies. Litrerature survey revealed that not 
much work is done on this plant. Therefore, it was thought worthwhile to carry out 
the phytochemical characterization and pharmacological studies on this plant. 
PHYTOCHEMICAL STUDIES 
Extraction of Leucas aspera (Willd.) Link Leaves 
 Dried crushed whole plant of Leucas aspera (Willd.) Link was extracted 
with petroleum ether and ethanol (90% v/v) continuously with soxhlet apparatus and 
the results were tabulated in Table 3. 
Table 3. Data showing the extractive values of whole plant of Leucas aspera (Willd) Link. 
S.No Extract Colour/ Physical nature Percentage yield (% w/w) 
1 Petroleum ether Green/ Waxy Semisolid 5.12 
2 Ethanol (90% v/v) Brownish Green/ Solid 6.09 
 
Preliminary Phytochemical Screening of whole plant of Leucas aspera (Willd.) 
Link. extracts  
The extracts of whole plant of Leucas aspera (Willd) Link. was subjected to 
qualitative phytochemical screening to identify the phytoconstituents present and the 
results were expressed in Table 4.
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Table 4. Preliminary Phytochemical Screening of whole plant of Leucas aspera 
(Willd.) Link. extracts 
S. No. Chemical Test Petroleum ether 
extract 
Ethanol 
(90% v/v)  extract 
1. Alkaloids   
a. Mayer’s Test - + 
b. Dragendroff’s Test - + 
c. Wagner’s Test - + 
d. Hager’s Test - + 
2. Carbohydrates   
a. Molisch’s Test + + 
b. Fehlings Test + + 
c. Barfoed’s Test + + 
d. Benedict’s Test + + 
3. Glycosides   
a. Legal’s Test - + 
b. Keller-Killiani Test - + 
c. Borntrager’s Test - + 
4. Fixed Oil & Fat   
a. Stain Test + - 
b. Saponification Test + - 
5. Tanins & Phenolics   
a. Ferric Chloride Test + + 
b. Lead Acetate Test + + 
c. Gelatin Solution Test + + 
6. Steroids   
a. Salkowsky’s Test + - 
b. Libermann Burchard’s Test + - 
7. Saponins   
a. Foam Test - + 
8. Proteins   
a. Million’s Test - - 
b. Ninhydrin Test - - 
9. Flavonoids   
a. Aqueous NaOH Test - + 
b. Conc.Sulphuric Acid Test - + 
c. Shinoda Test - + 
10. Gum & Mucilage - - 
11. Triterpenoids   
a. Knoller’s Test - - 
+ Present       - Absent 
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Thin Layer Chromatography (TLC) 
TLC was performed with various solvent systems based on the polarity by trial 
and error method. Ethanol extract of whole plant of Leucas aspera (Willd.) Link 
(EELA) was subjected to thin layer chromatography on silica gel G which had shown 
good resolution of solvent system toluene: ethyl acetate: acetic acid (55: 45: 1). Two 
spots were identified by means of corresponding detecting agent and Rf values were 
calculated and showed in Table 5 and Figure 4. 
Figure 4. Thin Layer Chromatography of EELA 
 
Table 5. Thin Layer Chromatography of EELA 
Solvent system No. of spots Spray reagent Rf Values 
Ethyl acetate : Chloroform (6:4) 1 Iodine vapour 0.57 
Chloroform: Methanol (96:4) 1 Iodine vapour 0.60 
Ethyl acetate: Formic acid: Water (50:4:10) 1 Iodine vapour 0.62 
Toluene: Ethyl acetate: Acetic acid (55: 45: 1) 2 Iodine vapour 0.63 
0.71 
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Column Chromatography 
On the basis of phytochemical screening and TLC study, isolation of active 
constituents of EELA was done by column chromatography through isocratic elution 
technique with the help of solvent system toluene: ethyl acetate: acetic acid (55: 45: 
1) was shown in Table 6 and Figure 5. 
Figure 5. Column Chromatography of EELA 
 
Table 6. Column Chromatography of EELA 
Fraction 
No. 
Nature of 
Residue 
Analysis by 
TLC 
Colour of 
the spot 
Rf 
Value 
1-4 No residue --- --- --- 
5-8 No residue --- --- --- 
9-12 Green --- --- --- 
13-16 Green ---- --- --- 
17-20 Light Green --- --- --- 
21-24 Greenish yellow 2 spots with 
tailing effect 
Yellow 
Greenish brown 
0.67 
0.70 
25-28 Light yellow 2 spots with 
tailing effect 
Yellow 
Brown 
0.71 
0.64 
29-32 Yellow  1 Yellow 0.63 
33-36 No residue --- --- --- 
37-40 No residue ---- ---- --- 
 
The isolated compound from the fraction 29-32 obtained by column 
chromatography was named as EELA I. 
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Analysis of the isolated compound 
Thin Layer Chromatography of the Isolated Compound EELA I 
 The isolated compound EELA I obtained from column chromatography was 
analyzed by chemical tests, thin layer chromatography using the solvent system 
toluene: ethyl acetate: acetic acid (55:45:1) and detected by iodine vapours.  EELA I 
showed the presence of one yellow colour spot with Rf value of 0.63 was shown in 
Figure 6. 
Characterization of EELA I 
Table 7. Results of chemical tests for EELA I 
Chemical Tests EELA I 
Aqueous NaOH Test Positive 
Conc.Sulphuric Acid Test Positive 
Shinoda Test Positive 
 
Table 8. Physical Characters of EELA I 
Parameters EELA I 
Yield 48 mg 
Physical state and color Yellow amorphous powder 
Solubility Water, acetone and DMSO 
Melting point 136 ºC 
TLC solvent system Toluene: Ethyl acetate: Acetic acid (55:45:1) 
Rf value 0.63 
 
Chapter 6 Results and Discussion 
Dept. of Pharmaceutical Chemistry 52 J.K.K.Nattraja College of Pharmacy 
Figure 6. Thin Layer Chromatography of EELA I 
 
 The isolated compound from the whole plant of Leucas aspera (Willd.) Link 
was tested and it showed the positive test for flavonoids. The physical characters of 
the compound were tabulated above.
Chapter 6 Results and Discussion 
Dept. of Pharmaceutical Chemistry 53 J.K.K.Nattraja College of Pharmacy 
 
 
 
 
 
 
 
 
 
Figure 7. IR Spectrum of isolated compound EELA I 
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Figure 8. 1H NMR Spectrum of isolated compound EELA I 
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Figure 9. Mass Spectrum of isolated compound EELA I 
Chapter 6 Results and Discussion 
Dept. of Pharmaceutical Chemistry 56 J.K.K.Nattraja College of Pharmacy 
The qualitative analysis of the ethanol extract of whole plant of Leucas 
aspera (Willd.) Link was summarized in Table 4. Preliminary phytochemical 
screening revealed that petroleum ether extract showed the presence of 
carbohydrates, fixed oils and fats, steroids, tannins & phenolics. Ethanol extract 
showed the presence of flavonoids, glycosides, tannins & phenolics, alkaloids, 
carbohydrates and saponins.  The TLC study was carried out and the results were 
summarized in Table 5. From the TLC study of the ethanol extract of Leucas aspera 
(Willd.) Link, the presence of two spots were observed as maximum number of 
spots with toluene: ethyl acetate: acetic acid (55:45:1) using iodine vapours as 
detecting agent. The Rf values of the spots were calculated and found to be 0.63, 
0.71 respectively. The results of column chromatography of the ethanol extract of 
Leucas aspera (Willd.) Link was summarized in Table 6. Phytochemical analysis of 
the isolated compound EELA I has shown positive result for flavonoids. 
Compound EELA-I was obtained as amorphous powder and its molecular 
formula was established as C15H10O5 from its mass spectral data that showed [M-H]- 
ion at m/z 268.08, 183.53, 172.06 & 149.05. The molecular formula of EELA-I was 
further supported by its IR, 1H NMR spectral data’s. The IR spectra exhibited 
characteristic bands at 3287.49 cm-1 for aromatic–OH groups, 1611.29 cm-1 for C=O 
group, 1186.35 cm-1 for C-O group and at 1655.30 cm -1 for C=C group. The 1H 
NMR spectrum showed the presence of broad peaks at δ10.36, 10.80 and at 12.95 
suggesting the presence of three phenyl hydroxyl groups. The 1H NMR spectrum of 
EELA-I also showed the presence of two meta coupled aromatic doublets at δ6.18 
and 6.45 corresponds to H-6 and H-8 protons, two doublets at δ6.95 (d,2H,J=6.4Hz) 
and 7.81 (d, 2H,J= 6.4Hz) for H-3'/H-5' and H-2'/H-6' protons of ring B, and a 
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singlet at δ6.73 corresponding to H-3 proton; characteristic for a 5,7,4'-trisubstituted 
flavone. Thus, according to the data and by comparison with the literature, the 
compound  was identified as Apigenin (Figure 10). 
Figure 10: Structure of Apigenin 
 
  
 
 
PHARMACOLOGICAL SCREENING 
In vitro Anticancer Activity 
The anticancer activity of ethanol extract of Leucas aspera was studied on 
the various cell line such as cervical cancer cell lines (HeLa), human liver cancer 
cell line (Hep G2) and human breast cancer cell lines (MCF-7) using MTT assay 
method. The EELA at doses of 62.5 µg/ml, 125 µg/ml,  250 µg/ml and 500 µg/ml 
produced a significant anticancer activity against HeLa, HepG2 and MCF-7 cancer 
cell lines. On comparison between the percentage cell inhibition of HeLa, Hep G2 
and MCF-7, the HepG2 (Human liver cancer cell line) showed higher inhibition and 
significant activity than the HeLa & MCF-7 which was mentioned in table 9 & 
figure 11.  
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Table 9.  % Cell Inhibition of EELA in HeLa, Hep G2 and MCF-7 Cell Lines 
Concentration 
(µg/ml) 
% Cell Inhibition 
HeLa HepG2 MCF-7 
62.5 16.65 35.48 12.15 
125 29.51 43.90 17.34 
250 37.09 56.81 25.67 
500 51.82 64.18 34.89 
 
Figure 11 
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Cancer is a disease caused by the abnormal proliferation and differentiation 
of cells and is governed by tumorigenic factors. Cancer is the second most common 
cause of human death worldwide. Currently, chemotherapy is still one of the best 
therapeutic methods to treat cancer. With wider application and further 
understanding, the side effects and acquired drug resistance of synthesized small 
molecule compounds have caused more and more concerns.51, 52 Therefore, natural 
and edible small molecules such as flavones, which are thought to have remarkable 
physiological effects, low toxicity and non-mutagenic properties in the human body, 
have gained more and more interest in anti-cancer agent development.  
Apigenin, known chemically as 4′, 5, 7-trihydroxyflavone, belongs to the 
flavone subclass and is abundant in vegetables, fruits and beverages, such as parsley, 
grapes, apples, chamomile tea and red wine. Apigenin is also one of the active 
ingredients in Indian medicinal herbs.        Apigenin has been used as a traditional 
medicine for centuries because of its physiological functions as an antioxidant and 
anti-inflammatory, its role in lowering blood pressure, and its antibacterial and 
antiviral properties.53-56 In addition to those effects, apigenin was proven to have 
tumor suppression efficacy in the last few decades. Since Birt et al. first reported 
that apigenin had anti-cancer activities in 1986, 57 more and more evidence has been 
presented to demonstrate that apigenin shows antitumor efficacy against various 
types of cancer with both cell lines in vitro and mouse models in vivo.  Apigenin has 
been demonstrated to show broad anti-cancer effects in various types of cancers; 
including colorectal cancer, breast cancer, liver cancer, lung cancer, melanoma, 
prostate cancer and osteosarcoma.58-63 This flavone inhibits cancer cell proliferation 
by triggering cell apoptosis, inducing autophagy and modulating the cell cycle. 
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Apigenin also decreases cancer cell motility and inhibits cancer cell migration and 
invasion. Recently, apigenin was reported to show anti-cancer activities by 
stimulating an immune response.64 During those processes, multiple signaling 
pathways and protein kinases are modulated by apigenin, including PI3K/AKT, 
MAPK/ERK, JAK/STAT, NF-κB and Wnt/β-catenin. The measurement of cell 
viability and growth is a valuable tool in a wide range of research areas. In the 
present study, HeLa, Hep G2 and MCF-7  cancer cell lines were used to study the 
cytotoxicity of the ethanol extract of Leucas aspera (Willd.) Link due to their well 
defined characteristics in experimental conditions and their relevance as an in vitro 
system for screening purposes involving natural products and antimutagenic effects 
on this cells.65, 66 The reduction of tetrazolium salts (MTT) is now recognized as a 
safe, accurate alternative to radiometric testing. Among the applications for the 
method are drug sensitivity, cytotoxicity, response to growth factors and 
activation.67, 68 HepG2 produced more significant in vitro anticancer activity than 
other two cell lines. Our findings shown that the antioxidant potentials like 
flavonoids, saponins present in extract might be responsible for the anticancer 
activities. Spectral datas of EELA I (Apigenin) also support anti cancer activity of 
Leucas aspera (Willd.) Link whole plant.  
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7. SUMMARY AND CONCLUSION 
Traditional Indian medicinal herbs have been used in the treatment of 
different diseases in the country for centuries. There have been claims that some 
traditional healers can successfully treat cancer using herbal drugs. The whole plant 
of Leucas aspera (Willd.) Link was selected and authenticated for the present study 
on the basis of ethanobotanical information.  
Literature survey revealed that not much work has done in this plant.  So I 
felt it worthwhile to validate scientifically, the folkclaim for its therapeutic activity.  
The detailed preliminary phytochemical investigations proved its appropriate 
identification and rationalized its use as a drug of therapeutic importance. This plant 
have many phytoconstituents like flavonoids, alkaloids, saponins, tannins and so on. 
The phytoconstituents are found to possess pharmacological activities like 
antioxidant, antiulcer, antiinflammatory, antimicrobial activities.  So it was planned 
to isolate active constituents  from ethanol extract of whole plant of Leucas aspera 
(Willd.) Link. The present study concluded that the phytoconstituent was isolated 
from the whole plant of ethanol extract of Leucas aspera (Willd.) Link and 
characterized systematically with IR, H1 NMR and mass spectroscopy.  The spectral 
datas of the isolated compound suggested that EELA I showed the structural 
similarities with Apigenin. 
Cancer is a complex multifactorial cell disease characterized by abnormal 
cellular proliferation. Cancer development is normally caused by oncogene, tumor 
suppressor gene, and microRNA gene alterations. It imposes a serious burden on the 
public health system, and its treatment and cure are scientifically challenging. 
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Cancer is expected to claim nine million lives worldwide by 2015. Approximately 
60% of anticancer agents are derived from medicinal plants and other natural 
resources; however, there are still a number of plants that have an anticancer 
potential but they have not yet been fully investigated. The MTT assay is used in 
screening the crude extracts as well as in the isolated compounds to assess the 
toxicity. It could also provide an indication of possible cytotoxic properties of the 
tested plant extracts. MTT assay is based on the reduction of MTT by mitochondrial 
dehydrogenase by purple formazan product. It is frequently used as an in vitro 
model system to measure cytotoxic effects of variety of toxic substances and plant 
extracts against cancer cell lines. Ethanol extract of Leucas aspera (Willd.) Link was 
screened for in vitro anticancer activitities in three different cell lines such as HeLa, 
Hep G2 and MCF-7 by MTT assay method.   HepG2 produced more significant in 
vitro anticancer activity than other two cell lines. The present study concluded that 
the antioxidant potentials like flavonoids, saponins present in extract might be 
responsible for the anticancer activities. 
 In conclusion, it was observed that the plant Leucas aspera (Willd.) Link 
contains a wide variety of secondary metabolites that hold strong antioxidant 
capacity based on the experiments performed which add scientific evidence to 
conduct further studies, investigate the lead compounds present in the plant, to 
evaluate its anticancer potential on in vivo animal models and put forward an attempt 
to carry out trials on human beings. 
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